Skip to content
CTD // Fund

One Ventures

Tech & Life Sciences focused VC firm investing in early stage startups in the US & Australia

← Fund directory

One Ventures

Australia

One Ventures is an institutional investor (Conventional VCs) founded in 2007 and headquartered in Sydney, Australia. One Ventures is a venture capital firm that invests in early-stage companies majorly in the United States, Australia and New Zealand. The firm invests in technology start-ups operating in areas such as HealthTech, FinTech, SaaS, EdTech and also in Life Sciences companies engaged in Biotechnology, Medical Devices, Diagnostics. Some of the notable portfolio companies include Hatchtech, Vaxxas, Smart Sparrow, Clinical Genomics Technologies, etc. The firm has $320M assets under management. Assets Under Management (AUM): $320M assets. Notable portfolio companies: Hatchtech, Vaxxas, Smart Sparrow, Clinical Genomics Technologies.

Stage
seed, Series A, growth, scale-up, late-stage, seed, Series A, growth, scale-up, late-stage
Check size
$500K-$30M
HQ
Sydney, Australia
Founded
2007
Website
https://one-ventures.com.au
LinkedIn
https://linkedin.com/company/ventures-one-ltd
Twitter
http://twitter.com/oneventuresvc
Institutional InvestorB2B technologySaaSfintechmarketplaceseCommerceenterprise softwarePropTechlogisticsroboticsIoT

What they look for

Primarily Australia and New Zealand (some Singapore), recurring revenue or subscription-based SaaS models, typically $3M-$15M revenue, strong product-market fit, quality leadership teams, large addressable markets with global potential, ESG-positive societal impact

Related startups

Preparing to pitch One Ventures?

CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.

Analyze My Deck →